CEACAM6 and neoplasm: Supporting this, is a recent study, by Blumenthal et al.[20], demonstrating that the addition of antibodies that inhibited the binding of CEACAM6+ve breast cancer cells to endothelial cells reduced tumour cell invasion[20].